References
- Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html. Accessed 1 February 2021.
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
- Primary Cutaneous Lymphomas (Version 1.2021). National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/primary_cutaneous.pdf. Accessed 2 Feburary 2021.
- NCCN: Cancer and COVID-19 Vaccination: Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee. National Comprehensive Cancer Network. https://www.nccn.org/covid-19/pdf/COVID-19_Vaccination_Guidance_V1.0.pdf. Accessed 2 February 2021.